Crypto News: Remittix Announces 300 Million RTX Burn at Launch as JPMorgan Brings Two Tokenized Funds to Solana, Building the Case for a $300 SOL Price Prediction Oct 25, 2026 09:50AM

Remittix prepares to remove 20% of its original token supply as JPMorgan expands institutional access to Solana through two tokenized money market funds.

MAJURO, Marshall Islands, Oct. 25, 2026 (GLOBE NEWSWIRE) -- Remittix has announced plans to burn 300 million RTX tokens at launch, removing 20% of its original supply as the project approaches its November 24, 2026 market debut. The burn brings a major tokenomics milestone into the final launch window alongside... (continue reading...)


ArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026 Oct 25, 2026 09:00AM
  • 44.8% ORR at 6mg/kg dose in late-line CRC patients  
  • ARR-217 was generally well-tolerated
  • ArriVent to host virtual webinar on Monday, October 26, 2026, at 8 am ET to discuss the data from the ARR-217 program

NEWTOWN SQUARE, Pa., Oct. 25, 2026 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced initial... (continue reading...)


Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Pati Oct 25, 2026 08:11AM

Pre-specified and Statistically Powered Key Endpoints Included Progression-free Survival (PFS) and Overall Survival (OS). Although Primary Endpoint of PFS Was Not Met, The Key Secondary Endpoint of OS Was Improved With VAZKEPA/VASCEPA

Patients Taking VASCEPA Prior to and Following Liver Resection for CRCLM Were Estimated to Have an Approximately 32% Reduction in the Risk of Death at 5 Years Relative to the Control Arm

DUBLIN and BRIDGEWATER, N.J., Oct. 25, 2026 ... (continue reading...)


AirTripMaker Launches Comprehensive Flight Tickets to India Routes Guide from the USA and Canada to Major Indian Destinations Oct 25, 2026 07:27AM

GERMANTOWN, Md., Oct. 25, 2026 (GLOBE NEWSWIRE) -- AirTripMaker, a growing travel platform focused on connecting travelers with convenient international air travel options, is expanding its USA and Canada to India travel network to serve passengers traveling from the United States or Canada to India’s most important metropolitan, business, technology, cultural and tourism destinations.

In 2026, finding a “deal” to India is no longer just about price—it’s about... (continue reading...)


NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development Oct 25, 2026 07:00AM
  • Updated Phase 1b dataset provides nearly 18 months of median follow-up and shows the durability of clinical benefit observed with givastomig
  • Clinical activity observed across CLDN18.2 expression levels, including in patients with lower-expression tumors not eligible for currently approved CLDN18.2-targeted therapies
  • Totality of efficacy, safety and long-term follow-up data supports selection of the 8 mg/kg dose for registrational development
  • Ongoing U.S. Food and Drug... (continue reading...)

More Globe Newswire

View Older Stories

Oct 25, 2026 07:00AM Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer
Oct 25, 2026 06:26AM Beyond Live Streaming: Tango Gives Back by Supporting Cancer Detection in Ukraine
Oct 25, 2026 06:22AM SI vs. AI: Super Intelligence Anomaly Outbreaks Trump’d by Clinton Legacy Tech (Veterans First for America)
Oct 25, 2026 05:15AM Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)
Oct 25, 2026 05:00AM KFSH Expands Virtual Care Pathways to Bring Specialized Follow-Up Closer to Patients
Oct 25, 2026 03:30AM BioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapy
Oct 24, 2026 07:30PM Climb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026
Oct 24, 2026 03:18PM Teck Provides Update on Highland Valley Copper Operations
Oct 24, 2026 02:00PM Online Cricket ID App Publishes Overview of Changing Digital Cricket Information Needs Among Indian Fans
Oct 24, 2026 01:56PM UK Financial Ltd Launches MAYA CHAIN and Begins Digital Asset Migration
Oct 24, 2026 01:10PM Get Cricket IDs Announces Online Information Resources for Live Cricket Updates, Match Statistics and Mobile Platform Access
Oct 24, 2026 12:35PM AI-119 Vulcan Force Solution Targets California's May 2027 Frontier AI Deadline (Veterans First for America)
Oct 24, 2026 12:35PM AI-119 Vulcan Force Solution Targets California's May 2027 Frontier AI Deadline (Veterans First for America)
Oct 24, 2026 10:00AM Melbourne coach Dominik Kulewski's Weight Loss Lab clients have now lost about 3 tonnes combined
Oct 24, 2026 10:00AM Melbourne coach Dominik Kulewski's Weight Loss Lab clients have now lost about 3 tonnes combined
Oct 24, 2026 09:28AM Widgets & Web Launches AI-Operated Investor Relations Websites for Public Companies at a Fixed $299 per Month
Oct 24, 2026 09:28AM Widgets & Web Launches AI-Operated Investor Relations Websites for Public Companies at a Fixed $299 per Month
Oct 24, 2026 09:00AM 2026 National Poppy Campaign launches with a donation “first” … and stunning mural: Don’t forget to Remember
Oct 24, 2026 09:00AM Thousands of Ontarians to Attend ‘Together for Publicly Funded Education’ Rallies
Oct 24, 2026 08:45AM Quanta Presents Positive Clinical Combination Data in KRAS G12D-Mutant CRC at ESMO and Highlights Pan-KRAS Progress
Oct 24, 2026 08:45AM Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors
Oct 24, 2026 08:20AM DEEP Robotics Unveils Five Research Advances in Embodied AI
Oct 24, 2026 08:09AM JST Buyback & Burn Upgrade: GasFree Revenue and $20.34M Surplus Injected as JUST's Ecosystem Trio Solidifies JST Token Value
Oct 24, 2026 08:09AM JST Buyback & Burn Upgrade: GasFree Revenue and $20.34M Surplus Injected as JUST's Ecosystem Trio Solidifies JST Token Value
Oct 24, 2026 07:00AM NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma
Oct 24, 2026 07:00AM Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
Oct 24, 2026 06:47AM Asyad Group to Host Muscat Maritime Resilience Forum to Strengthen Global Trade Networks
Oct 24, 2026 05:00AM KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
Oct 24, 2026 04:47AM AirTripMaker Launches Comprehensive Business Class Flight Routes Guide from the USA to 15 Major International Destinations and Regions
Oct 24, 2026 04:15AM Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026
Oct 24, 2026 04:15AM Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026
Oct 24, 2026 02:35AM Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence
Oct 24, 2026 02:30AM Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
Oct 24, 2026 02:30AM Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting
Oct 24, 2026 02:25AM Yangguang News Launches Global Youth Short Video Campaign “Me, Tang Poetry, and AI”
Oct 24, 2026 12:44AM World Famous Liquor Brands Sustainability Index Report (2026) Released
Oct 24, 2026 12:17AM Rooted in the River, Renewed with the Times: Insights from the 2026 Chishui River Forum
Oct 23, 2026 11:30PM Junshi Biosciences Announces Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS203 in Combination with Chemotherapy for the Treatment of Diffuse Large B-cell Lymphoma
Oct 23, 2026 10:06PM See It, Try It, Compare It: SIVP Brings CHERY’s “Technology. For Family” to Life
Oct 23, 2026 10:00PM Vmake Labs Launches All-in-One Halloween Social Video Toolkit for SMBs
Oct 23, 2026 09:50PM Amaggi Luxembourg International S.à r.l. Announces Expiration and Results of Its Cash Tender Offer for Up to U.S.$300 Million Aggregate Principal Amount of Its 5.250% Notes Due 2028
Oct 23, 2026 09:23PM Urban Seed Logs Record Harvest in 15th Season, Sets 2027 Focus on Building an Organization That Lasts
Oct 23, 2026 09:21PM SuperClean Restoration Of The Palm Beaches LLC Surpasses 100+ Google Reviews, Solidifying Its Reputation as the Most Trusted Name in Water Damage Restoration in Wellington, FL
Oct 23, 2026 08:30PM Shalaan Umar is America’s Top Young Innovator 2026 as Young Inventors Earn Global Recognition for Breakthrough Innovations
Oct 23, 2026 08:00PM RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
Oct 23, 2026 07:01PM Reid Collins & Tsai LLP Notifies Holders of Navios Maritime Holdings, Inc.’s Preferred ADS of Deficiencies in Navios’s Recent Tender Offer Documentation
Oct 23, 2026 06:49PM Mirasol Resources Announces Option Grants
Oct 23, 2026 06:29PM Clearwater Properties Broker Hannah Bruha Named a "Star on the Rise" by Montana Real Producers
Oct 23, 2026 06:17PM Black Rock Coffee Bar Continues Expansion in California with New Rancho Cucamonga Location
Oct 23, 2026 06:14PM LUNR Aerospace Corporation Obtains Receipt for Final Prospectus Accessible on SEDAR+
View Older Stories